Accessibility Statement

Skip to main content

Lilly.com
Investors
Contact

Menu closed

Our Strategy
ESG Strategy

ESG Goals

CEO Letter

About This Report

Latest ESG Developments
Environmental
Our Approach and Goals

Climate

Waste

Water

Product Stewardship
Social
Our Approach and Goals

Access & Affordability

Community Engagement

Diversity, Equity & Inclusion

Employee Well-Being

Human Rights

Patient Safety
Governance
Our Approach

Business Ethics

Corporate Governance

Supply Chain Management
Transparency
ESG Metrics

SASB Index

SDGs

TCFD

UNGC Index

Reports & Policies

Lilly.com
Investors
Contact

article-header-NIDA30x30 Research15033 5048

Repurposing Early-Phase Therapies to Drive Social Impact

Eli Lilly and Company | March 3, 2022

Tags | ESG

Loading...

Loading...

Loading...

Loading...

Diversity
Contact
Suppliers
Login

Terms of Use
Privacy Statement
Accessibility Statement
Sitemap

To speak to customer support:
Call (800) 545-5979

Copyright © 2022 Eli Lilly and Company. All rights reserved.

Terms of Use Privacy Statement Accessibility Statement Sitemap